Oportunitati de finantare
This presentation is the property of its rightful owner.
Sponsored Links
1 / 40

Oportunitati de finantare PowerPoint PPT Presentation


  • 95 Views
  • Uploaded on
  • Presentation posted in: General

Oportunitati de finantare. Letitia Clara Stanila Ministerul Educatiei, Cercetarii, Tineretului si Sportului Autoritatea Nationala pentru Cercetare Stiintifica [email protected] Cuprins. The 7 th Framework Programme ERA-NETs Joint Programming Initiatives Norway Grants

Download Presentation

Oportunitati de finantare

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Oportunitati de finantare

Oportunitati definantare

Letitia Clara Stanila

Ministerul Educatiei, Cercetarii, Tineretului si Sportului

Autoritatea Nationala pentru Cercetare Stiintifica

[email protected]


Cuprins

Cuprins

The 7th Framework Programme

ERA-NETs

Joint Programming Initiatives

Norway Grants

European Economic Area Grants

European Science Foundation


Ce este programul cadru 7

Ce este Programul Cadru 7?

Programul cadru pentru cercetare, dezvoltare tehnologica si activitati demonstartive reprezinta instrumentul prin care Uniunea Europeana sprijina domeniul stiintei si tehnologiei la nivel european.

Obiectivul Lisabona:

  • Până în anul 2010 Europatrebuie “… să devină cea mai competitivă şi dinamică economie din lumebazată pe cunoaştere, capabilăsă dezvolte o economie durabilă care să ofere mai multe şi mai bune locuri de muncă şi să asigure coeziunea socială.”

    - Consiliul Miniştrilor de la Lisabona din martie 2000

  • Suport pentru alte politici:

    • Sanatate

    • Agricultura

    • Mediu

    • Cooperare internationala


Istorie programe cadru

Istorie Programe Cadru


Structura pc7 2007 2013

Structura PC7 2007-2013


Oportunitati de finantare

  • Consiliul European de Cercetare - ERC

  • “Frontier Science”

  • abordare de “jos in sus”

  • criteriu unic – excelenta

  • grup tinta : echipa unica sau consortii nationale sau internationale

  • doua tipuri de granturi: Starting Independent Researcher Grants si Advanced Investigator Grants

  • Programul Idei incurajeaza participarea cercetatorilor din tari europene si non-europene

  • Nivelul de participare variaza in ceea ce priveste rolurile si finantarea

  • Investigator principal – pot fi de orice nationalitate dar organizatia gazda a IP trebuie sa fie intr-o tara membra UE sau asociata, sau o organizatie internationala precum CERN, EMBL, etc., sau JRC

  • Membrii echipei pot fi de orice varsta si nationalitate


Oportunitati de finantare

FORMAREA INITIALA A CERCETATORILOR

pentru a imbunatati perspectivele de cariera a tinerilor cercetatori din sectorul public si privat

FORMARE DE LUNGA DURATA SI DEZVOLTARREA CARIEREI

Pentru a sprijini cercetatori cu experienta in dobandirea de noi aptitudini si competente.

PARTENERIATE INTRE INDUSTRIE SI MEDIUL ACADEMIC

pentru stimularea mobilitatii intersectoriale

DIMENSIUNEA INTERNATIONALA

Pentru a promova colaborarea stiintifica cu cercetatori din afara Europei.

ACTIUNI SPECIFICE

Pentru a inlatura obstacolele in calea mobilitatii si imbunatatirii perspectivelor de cariera pentru cercetatorii din Europa.


Oportunitati de finantare

Infrastructuri de cercetare

Cercetare în beneficiul IMM-urilor

Regiuni ale cunoaşterii

Potenţialul de cercetare al Regiunilor de Convergenţă

Ştiinţa în societate

Sprijin pentru dezvoltarea coerentă a politicilor de cercetare

Cooperare internaţională


Oportunitati de finantare

e.g. Alergies, Food intolerance

e.g. e-Health

e.g. Nanobiotechnology, Nanoparticles

e.g. Environment and Health

e.g. „public health“

e.g. Bioterrorism


Oportunitati de finantare

Aspectetransversale: cooperareinternationala, IMM-urile, sanatateacopiilor, imbatranireapopulatiei, probleme de sanatatecaracteristicefemeiisaubarbatului

  • Pricipalele obiective politice:

  • Ameliorarea sanatatii cetatenilor europeni

  • Cresterea competitivitatii industriei si afacerilor din domeniul sanatatii la nivel european

  • Abordarea problemelor globale de sanatate, inclusiv epidemiile emergente


Scopul activitatii de cercetare in sanatate

Scopul activitatii de cercetare in “Sanatate”

Finantarea este acordata cercetarii fundamentale si aplicate

Incluzand inovatii, cercetare translationala si studii clinice

de faza I, II, III si chiar IV!


Activitatea 1 biotehnologie instrumente generice tehnologii pentru sanatate

Activitatea 1: Biotehnologie, Instrumente generice & Tehnologii pentru sanatate

Scop:

Dezvoltarea si validarea instrumentelor si tehnologiilor pentru producerea de noi cunostinte si traducerea lor in aplicarea practica in domeniul sanatatii si medicamentelor

1.1 High-throughput research

HEALTH.2011.1.1-1: SME-targeted research for developing tools and technologies for high-throughput research. FP7-HEALTH-2011-two-stage

HEALTH.2011.1.1-2: Genome-based biomarkers for patient stratification and pharmacogenomic strategies. FP7-HEALTH-2011-two-stage.

HEALTH.2011.1.1-3: High-throughput proteomics for human health and disease. FP7-HEALTH-2011-single-stage.


Activitatea 1 biotehnologie instrumente generice tehnologii pentru sanatate1

Activitatea 1: Biotehnologie, Instrumente generice & Tehnologii pentru sanatate

1.2 Detection, diagnosis and monitoring - Closed in 2011

1.3 Innovative therapeutic approaches and interventions - Closed in 2011

1.4 Predicting suitability, safety and efficacy of therapies (including alternatives to animal testing)

HEALTH.2011.1.4-1: Regenerative medicine clinical trials. FP7-HEALTH-2011-twostage.

HEALTH.2011.1.4-2: Tools, technologies and devices for application in regenerative medicine. FP7-HEALTH-2011-two-stage.

HEALTH.2011.1.4-3: Development and production of new, high-affinity protein scaffolds for therapeutic use. FP7-HEALTH-2011-two-stage.

HEALTH.2011.1.4-4: High impact research initiative for better immunisation. FP7-HEALTH-2011-single-stage.

HEALTH.2011.1.4-5: New therapeutic approaches in chronic inflammatory and autoimmune diseases. FP7-HEALTH-2011-single-stage.


Activitatea 2 transpunerea rezultatelor cercetarii pentru sanatate

Activitatea 2: Transpunerea rezultatelor cercetarii pentru sanatate

Scop:

Dezvoltarea cunoasterii proceselor biologice si mecanismelor implicate in sanatate si boala si transpunerea in aplicatii clinice

2.1 Integrating biological data and processes: large-scale data gathering, systems biology

2.1.1 Large-scale data gathering

HEALTH.2011.2.1.1-1: High impact research initiative on the human epigenome. FP7-HEALTH-2011-single-stage.

HEALTH.2011.2.1.1-2: Proteins and their interactions in health and disease. FP7-HEALTH-2011-two-stage.

HEALTH.2011.2.1.1-3: Large-scale genomics approaches to identify host determinants of infectious diseases. FP7-HEALTH-2011-two-stage.

HEALTH.2011.2.1.1.-4: Population genetics studies on cardio-metabolic disorders in EU/AC and EECA populations. FP7-HEALTH-2011-single-stage.

2.1.2 Systems biology - Closed in 2011


Activitatea 2 transpunerea rezultatelor cercetarii pentru sanatate1

Activitatea 2: Transpunerea rezultatelor cercetarii pentru sanatate

2.2 Research on the brain and related diseases, human development and aging

2.2.1 Brain and brain-related diseases

HEALTH.2011.2.2.1-1: Investigator-driven clinical trials for childhood-onset

neurodegenerative diseases. FP7-HEALTH-2011-two-stage

HEALTH.2011.2.2.1-2: Understanding the role of neuroinflammation in

neurodegenerative diseases. FP7-HEALTH-2011-two-stage.

HEALTH.2011.2.2.1-3: Addictive and/or compulsive behaviour in children and adolescents: translating pre-clinical results into therapies. HEALTH-2011-two-stage.

HEALTH.2011.2.2.1-4: Creating clinical and molecular tools for experimental therapy of paediatric neurodegenerative disorders causing childhood dementia in Europe and India. FP7-HEALTH-2011-single-stage.

HEALTH.2011.2.2.1-5: ERA-Net on disease-related neurosciences. FP7-ERANET-2011-RTD.


Activitatea 2 transpunerea rezultatelor cercetarii pentru sanatate2

Activitatea 2: Transpunerea rezultatelor cercetarii pentru sanatate

2.2 Research on the brain and related diseases, human development and aging

2.2.2 Human development and ageing

HEALTH.2011.2.2.2-1: Investigator-driven clinical trials for therapeutic interventions in elderly populations. FP7-HEALTH-2011-two-stage.

HEALTH.2011.2.2.2-2: Linking human development and ageing. FP7-HEALTH-2011-two-stage.


Activitatea 2 transpunerea rezultatelor cercetarii pentru sanatate3

Activitatea 2: Transpunerea rezultatelor cercetarii pentru sanatate

2.3Translational research in major infectious diseases (HIV/Aids, malaria, tuberculosis etc.) anti-microbial drug resistance and new emerging epidemics (SARS etc.)

2.3.1 Anti-microbial drug resistance

HEALTH.2011.2.3.1-1 Investigator-driven clinical trials of off-patent antibiotics. FP7-HEALTH-2011-two-stage.

HEALTH.2011.2.3.1-2: Multi-disciplinary research on the evolution and transfer of antibiotic resistance. FP7-HEALTH-2011-single-stage.

HEALTH.2011.2.3.1-3 Management of Gram negative multi-drug resistant infections. FP7-HEALTH-2011-single-stage.

HEALTH.2011.2.3.1-4 Development of multi-analyte diagnostic tests. FP7-HEALTH-2011-two-stage.

HEALTH.2011.2.3.1-5 Development of tools to control microbial biofilms with relevance to clinical drug resistance. FP7-HEALTH-2011-two-stage.

2.3.2 HIV/AIDS, malaria and tuberculosis – closed in 2011


Activitatea 2 transpunerea rezultatelor cercetarii pentru sanatate4

Activitatea 2: Transpunerea rezultatelor cercetarii pentru sanatate

2.3Translational research in major infectious diseases (HIV/Aids, malaria, tuberculosis etc.) anti-microbial drug resistance and new emerging epidemics (SARS etc.)

2.3.3 Potentially new and re-emerging epidemics

HEALTH.2011.2.3.3-1: Identification of factors promoting the emergence of pathogens with human pandemic potential from pathogens with a zoonotic background and related prevention strategies. FP7-HEALTH-2011-two-stage.

HEALTH.2011.2.3.3-2: Comprehensive control of Dengue fever under changing climatic conditions. FP7-HEALTH-2011-single-stage.

HEALTH.2011.2.3.3-3: Development of an evidence-based behavioural and

communication package to respond to major epidemic outbreaks. FP7-HEALTH-2011-two-stage.

2.3.4 Neglected infectious diseases - Closed in 2011


Activitatea 2 transpunerea rezultatelor cercetarii pentru sanatate5

Activitatea 2: Transpunerea rezultatelor cercetarii pentru sanatate

2.4 Translational research in other major diseases: Cancer, cardiovascular diseases, diabetes und obesity, rare diseases, other chronic diseases (e.g. rheumatoid diseases)

2.4.1 Cancer

HEALTH.2011.2.4.1-1: Investigator-driven treatment trials for rare cancers. FP7-HEALTH-2011-two-stage.

HEALTH.2011.2.4.1-2: Translational research on cancers with poor prognosis. FP7-HEALTH-2011-two-stage.

HEALTH.2011.2.4.1-3: Epidemiology and aetiology of infection-related cancers. FP7-HEALTH-2011-single-stage.

2.4.2 Cardiovascular diseases –CVD

HEALTH.2011.2.4.2-1: Investigator-driven clinical trials for the management of cardiovascular diseases. FP7-HEALTH-2011-two-stage.

HEALTH.2011.2.4.2-2: Evaluation and validation studies of clinically useful biomarkers in prevention and management of cardiovascular diseases. FP7-HEALTH-2011-twostage.


Activitatea 2 transpunerea rezultatelor cercetarii pentru sanatate6

Activitatea 2: Transpunerea rezultatelor cercetarii pentru sanatate

2.4 Translational research in other major diseases: Cancer, cardiovascular diseases, diabetes und obesity, rare diseases, other chronic diseases (e.g. rheumatoid diseases)

2.4.3 Diabetes and obesity

HEALTH.2011.2.4.3-1: Investigator-driven clinical trials to reduce diabetes complications. FP7-HEALTH-2011-two-stage.

HEALTH.2011.2.4.3-2 Development of novel treatment strategies based on knowledge of cellular dysfunction. FP7-HEALTH-2011-two-stage.

HEALTH.2011.2.4.3-3: Molecular and physiological effects of lifestyle factors on diabetes/obesity. FP7-HEALTH-2011-two-stage.

HEALTH.2011.2.4.3-4: Genetic and environmental factors in obesity and/or diabetes in specific populations. FP7-HEALTH-2011-two-stage.

HEALTH.2011.2.4.3-5: ERA-NET on diabetes prevention and treatment. FP7-

ERANET-2011.

2.4.4 Rare diseases - Closed in 2011

2.4.5 Other chronic diseases - Closed in 2011


Activitatea 3 optimizarea asigurarii conditiilor de sanatate

Activitatea 3: Optimizarea asigurarii conditiilor de sanatate

Scop:

Furnizarea bazei necesare pentru politici si luarea deciziilor privind sistemele de sanatate si pentru strategii de promovare eficienta a sanatatii, prevenirea bolilor, diagnostic si terapie

3.1 Translating the results of clinical research outcome into clinical practice including better use of medecines, and appropriate use of behavioural and organisational interventions and new health therapies and technologies -Closed in 2011

3.2 Quality, efficiency and solidarity of healthcare systems including transitional health systems - closed in 2011


Activitatea 3 optimizarea asigurarii conditiilor de sanatate1

Activitatea 3: Optimizarea asigurarii conditiilor de sanatate

3.3 Health promotion

HEALTH.2011.3.3-1: Developing methodologies to reduce inequities in the determinants of health. FP7-HEALTH-2011-two-stage

HEALTH.2011.3.3-2: Analysis of integrated strategies for sustainable behaviour change. FP7-HEALTH-2011-two-stage.

HEALTH.2011.3.3-3: Developing and implementing methods for the transfer of research into policy in the fields of health promotion and disease prevention. FP7-HEALTH-2011-single-stage.

HEALTH.2011.3.3-4: A road-map for mental health research in Europe. FP7-

HEALTH-2011-single-stage.

HEALTH.2011.3.4-1: Development and assessment of comprehensive and integrated interventions and programmes to improve reproductive health and health equity. FP7-HEALTH-2011-single-stage.

HEALTH.2011.3.4-2: Building sustainable capacity for research for health and its social determinants in low and middle income countries. FP7-HEALTH-2011-single-stage.

HEALTH.2011.3.4-3: Multilateral cooperation between Europe, Africa and Latin America on public health and health services research. FP7-HEALTH-2011-single-stage.


Activitatea 4 actiuni transversale

Activitatea 4: Actiuni transversale

4.1 Coordination and support actions across the theme

HEALTH.2011.4.1-1: Networking of major research institutions to coordinate communication actions aimed at the media and the general public. FP7-HEALTH-2011-single-stage.

HEALTH.2011.4.1-2: Targeting publication bias. FP7-HEALTH-2011-single-stage.

HEALTH.2011.4.1-3: Linking EU and Latin American policy making institutions in the field of health research. FP7-HEALTH-2011-single-stage.

HEALTH.2011.4.1-4: Organisation of supporting actions and events related to the Presidency of the European Union. FP7-Health-2011-single-stage.


Activitatea 4 actiuni transversale1

Activitatea 4: Actiuni transversale

4.2 Responding to eu policy needs

HEALTH.2011.4.2-1: Investigator-driven clinical trials on off-patent medicines for children. FP7-HEALTH-2011-single-stage.

HEALTH.2011.4.2-2: Adverse drug reaction research. FP7-HEALTH-2011-single-stage.

HEALTH.2011.4.2-3: New methodologies for clinical trials in personalised medicine FP7-HEALTH-2011-single-stage.


Termene limita

Termene limita

FP7-HEALTH-2011-single-stage - 10 November 2010 at 17:00:00 (Brussels local time); Indicative budget: 160.50 Mil. Euro

FP7-HEALTH-2011-two-stage - stage 1 - 13 October 2010 at 17:00:00 (Brussels local time); Indicative budget: 498 Mil. euro


Inceputul

Inceputul …

IDEEA DVS TREBUIE SA FIE INOVATIVA

- http://www.epo.org/patents/patent-information.html

  • http://www.osim.ro/

  • www.ipr-helpdesk.org

  • Proiecte finantate anterior in PC6 si PC7

  • http://cordis.europa.eu/fp6/projects.htm

  • http://cordis.europa.eu/fp7/projects_en.html


Oportunitati de finantare

Undegasescapelurile?

http://cordis.europa.eu/fp7/dc/index.cfm


Documente necesare

Documente NECESARE

Call fiche – anuntul oficial

Work Programme –Health

Guide for applicants (pe tip de proiect)

Regulile de participare

Modelul de acord de grant

Regulile financiare

ESENTIALE!


Era nets

ERA-NETs

ERA-AGE 2 – extension

EUROCOURSE – Europe against cancer: Optimisation of the use of registries for scientific excellence in research

HIVERA – Harmonizing, integrating and vitalizing European research on AIDS/HIV

NEURON 2– Network of European Funding for Neuroscience Research –under preparation

TRANSCAN – ERA-NET on translational cancer research – under preparation


Joint programming initiatives

Joint Programming Initiatives

Antimicrobial resistance

A healthy diet for a healthy life


Norway grants http www norwaygrants org

NORWAY GRANTShttp://www.norwaygrants.org

Obiectivul general este de a stimula cresterea economica si dezvoltarea durabila si promovarea transferului de tehnologie

  • Reducerea emisiilor de gaze cu efect de sera

  • Eficienta energetica si energie regenerabila

  • Productie durabila, inclusiv certificare si validare

  • Sanatate


European economic area grants http www eeagrants org

European Economic Area GRANTShttp://www.eeagrants.org/

Obiectivul general este de a contribui la reducerea disparitatilor economice si sociale din Europa

Cercetare academica in domeniile: mediu si sanatate


European science foundation

European Science Foundation

http://www.esf.org/

European Science Foundation (ESF) este o asociaţie de 79 organizaţii membre dedicate cercetării ştiinţifice în 30 de ţări europene.

Scopul de bază al ESF este de a promova ştiinţa de înaltă calitate la nivel european. ESF faciliteaza cooperarea şi colaborarea în domeniul ştiinţei, în numele părţilor sale interesate (organizaţiile membre şi comunitatea ştiinţifica din Europa).

Această activitate transfrontalieră combină abordări atât "de sus în jos“ şi "de jos în sus".

3 piloni principali: Science Strategy, Science Synergy, Science Management.


European science foundation1

European Science Foundation

Science Strategy

Strategia cuprinde acele activităţi care sunt orientate spre viitor şi se ocupe cu probleme de politică de importanţă europeană, în scopul de a identifica direcţiile viitoare de cercetare şi a priorităţilor.

Instrumente: Forward Looks, Member Organisation Fora, Exploratory Workshops

Science Synergy

Activităţile din cadrul acestui pilonul reuneste cercetători şi organizaţii membre în scopul de a planifica şi implementa activitati de cercetare la nivel european.

Instrumente: EUROCORES, ESF Research Networking Programmes si ESF Research Conferences

Science Management

Cuprinde furnizarea de servicii şi expertiză in mamagement de programe.

Exemplu: European Young Investigator Awards (EURYI)


Cateva secrete perspectiva

Cateva secrete - PERSPECTIVA

• Propunerea dvs trebuie scrisa pentru a rezolva o problema EUROPEANA indentificata in politicile UE – NICIODATA sa nu lasati impresia ca scrieti proiectul pentru gasi finantarea cercetarii dvs.!


Cateva secrete sprijin

Cateva secrete - SPRIJIN

  • Solicitati sprijinul PNC privind “consistenta” proiectului dvs.

  • Nu considerati in proiectul dvs numai aspectele stiintifice, ci si cele politice, economice si sociale!


Reteaua ncp urilor

RETEAUA NCP-urilor

RETEAUA PUNCTELOR NATIONALE DE CONTACT


Scrierea propunerii cateva sugestii

Scrierea propunerii – cateva sugestii

  • Utilizati engleza standard si concisa

  • Textul sa fie clar, bine structurat si fluent

  • Utilizati paragrafe scurte, marcati pasajele-cheie, schematizati conceptele

  • Inserati numai informaţiile relevante pentru proiect

  • Raspundeti la TOATE intrebarile din formular

  • Utilizati terminologia relevanta in Programul de Lucru

  • Fiti coerenti in toate paragrafele propunerii (ex: service – system, experimentation – test, etc.)

  • Introduceti conceptele noi inca de la inceput si explicati-le, nu le introduceti la sfarsit

  • Referiti-va la date statistice publice daca sunt relevante

  • Referiti-va la proiecte finantate anterios

  • Utilizati grafice, diagrame, tabele, in loc de sute de cuvinte!

  • Faceti propunerea citibila – evaluatorul are cateva ore timp sa citeasca propunerea dvs si sa o evalueze.

  • Scrieti cu caractere cursive, subliniate, ingrosate


Oportunitati de finantare

Va multumesc pentru atentie!


  • Login